Pomerantz LLP is investigating claims against Yiren Digital Ltd. for possible securities fraud following the company's disclosure of a 34% revenue decline and a significant net loss in Q4 2025. The company also reported increased delinquency rates and a sharp rise in contingent liabilities, which led to a 44.84% drop in its ADR price. Additionally, Yiren's CEO Ning Tang was subjected to criminal compulsory measures related to an investigation involving affiliates of the controlling shareholder, causing another 44% ADR price fall. This investigation could impact investor confidence and the company's future operations.
Regarding the investigation into Yiren Digital Ltd., here is Pluang's snapshot of the Financials sector as of Nov 04, 2026 05:11 WIB: Out of 142 priced US Financials stocks tradable on Pluang, 51 rose and 91 fell today. Notable movers include MRX (Marex Group Limited Ordinary Shares) at USD 68.27 with a 1-day change of +5.19% and a typical hold time of 11 days, CRCL (Circle Internet Group Inc. Class A Common Stock) at USD 75.70 up 5.02% with a 12-day hold time, and APO (Apollo Global Management Ord Shs) at USD 114.11 down 4.48%, with Pluang order activity showing 21% Sell and 79% Buy, and a typical hold time of 70 days.
Nova Klúbburinn hf. has completed a share buyback program, acquiring 122,699,386 shares at an average price of ISK 3.26 per share. The buyback was part of an inverse offer process with valid bids for 159,526,476 shares. The company accepted bids up t...
Pomerantz LLP is investigating DaVita Inc. for potential securities fraud following a significant stock price drop triggered by a new federal kidney care strategy announced by the U.S. Department of Health and Human Services. The plan aims to increas...
3M has agreed to a $7.35 billion nominal settlement, with a present value of $5.8 billion, to resolve approximately 99% of PFAS-related personal injury claims involving up to 120,000 plaintiffs. This settlement reduces litigation uncertainty and alig...
Pomerantz LLP is investigating claims against Evolus, Inc. following an FDA warning about misleading Instagram promotions for its wrinkle treatment Jeuveau. The FDA criticized the ads for minimizing safety risks and making exaggerated claims about th...
Pomerantz LLP is investigating Neogen Corporation following an FDA warning about its veterinary wound care product, Neogen Vet HYCOAT, which was linked to serious infections and at least 20 horse deaths. This represents the largest number of horse de...
